Join the 'Venous Thromboembolism' group to help and get support from people like you. How it works
Venous Thromboembolism Blog
| Tweet |
Aspirin May Prevent Recurrence of Deep Vein Blood Clots
Posted 5 days ago by Drugs.com
WEDNESDAY, May 23 – After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, according to a new Italian study. Blood-thinning, or "anticoagulant," therapy is used to prevent another clot, which occurs in about 20 percent of patients. However, extended use of warfarin can increase the risk for bleeding, so researchers wanted to know whether aspirin would be a good alternative after two years of treatment with warfarin. "Aspirin given after a standard course of anticoagulant treatment may reduce recurrence of venous thromboembolism without increasing complications," said lead researcher Dr. Cecilia Becattini, from the Internal and Cardiovascular Medicine and Stroke Unit at the University of Perugia. So aspirin can be an alternative after an initial ... Read more
Related support groups: Aspirin, Ecotrin, Bayer Aspirin, Bufferin, St Joseph Aspirin, ZORprin, Aspergum, Buffered Aspirin, Easprin, Venous Thromboembolism, Bayer Childrens Aspirin, Gennin-FC, Aspir-Low, Ecotrin Maximum Strength, Halfprin
Blood Clot Risk for Outpatients Needs More Attention: Study
Posted 27 Apr 2012 by Drugs.com
FRIDAY, April 27 – People undergoing outpatient surgery should be warned about their risk for dangerous blood clots, according to a new study that finds the risk is higher among groups including, but not limited to, those who are older or obese. The University of Michigan researchers found that one in 84 patients considered high-risk suffers a blood clot after outpatient surgery. More than 60 percent of operations are currently performed as outpatient procedures, according to background information in a university new release. "Outpatient surgery now includes a greater variety of procedures, from plastic surgery to cancer operations and orthopedic surgery, and not all patients are young, healthy individuals," lead study author Dr. Christopher Pannucci, a University of Michigan plastic surgeon, said in the news release. "These data are in stark contrast to provider and patient ... Read more
Related support groups: Surgery, Venous Thromboembolism
New Blood Thinner May Prevent Blood Clots During Cancer Treatment
Posted 15 Feb 2012 by Drugs.com
WEDNESDAY, Feb. 15 – A new blood-thinning medication called semuloparin reduces the risk of blood clots in people undergoing certain cancer treatments, new research shows. When people with cancer are treated with chemotherapy, they have an increased risk of developing blood clots (venous thromboembolism). These clots can be dangerous, and have the potential to cause heart attacks or strokes. This new drug reduced the risk of blood clots by 64 percent, according to the study, which was funded by Sanofi, the drug's manufacturer. Sanofi was also responsible for the analysis of the study's results. Semuloparin, which is not currently approved by the U.S. Food and Drug Administration, didn't appear to increase the risk of excessive bleeding, which can be a side effect of blood thinners. "Thromboembolism and the effects are very significant," said Dr. Stephanie Bernik, chief of surgical ... Read more
Related support groups: Venous Thromboembolism
Cancer Outpatients at Greater Risk for Blood Clots
Posted 13 Dec 2011 by Drugs.com
MONDAY, Dec. 12 – Cancer patients receiving chemotherapy most often develop blood clots after they are discharged from the hospital, according to a large new study. Efforts to prevent this common and potentially life-threatening complication of cancer treatment should focus on outpatients – not those still in the hospital, the researchers said. A blood clot, also called a venous thromboembolism (VTE), is a mass of red blood cells, clotting proteins and platelets that block the flow of blood. Once cancer patients develop one clot, they're much more likely to develop others, according to a news release from the University of Rochester Medical Center. "One in five patients develops blood clots after a cancer diagnosis and we believe that number is rising," study author Dr. Alok Khorana, an associate professor in the James P. Wilmot Cancer Center at URMC, said in the release. After ... Read more
Related support groups: Venous Thromboembolism
Low-Dose Aspirin After Lung Clot Could Prevent Recurrence
Posted 11 Dec 2011 by Drugs.com
SATURDAY, Dec. 10 – Giving low-dose aspirin to patients after they've received stronger blood thinners for dangerous clots in the lungs could cut their odds of redeveloping the clots, a new study finds. The clots in question are venous thromboembolisms (VTEs). These can include both the leg clots known as deep-vein thromboses, or pulmonary embolisms, clots in the lungs that can cause rapid pulse, shortness of breath, chest pain and even death. Patients with VTE are typically given anticoagulants such as warfarin (Coumadin) to help prevent future clots and dissolve existing clots in the veins. However, about 15 to 20 percent of VTE patients redevelop blood clots within two years after completing such treatment, according to background information in the study. Extending blood thinner treatment with powerful medicines such as warfarin can prevent recurrences, but it also carries an ... Read more
Related support groups: Aspirin, Ecotrin, Bayer Aspirin, Bufferin, St Joseph Aspirin, ZORprin, Aspergum, Buffered Aspirin, Easprin, Venous Thromboembolism, Bayer Childrens Aspirin, Gennin-FC, Aspir-Low, Ecotrin Maximum Strength, Halfprin
Life-Threatening Leg Clots Run in Families, Study Shows
Posted 8 Aug 2011 by Drugs.com
MONDAY, Aug. 8 – People who have two or more siblings who have suffered blood clots in deep veins such as those in the legs and pelvis – a disease known as venous thromboembolism (VTE) – have a relative risk 50 times higher for developing such clots themselves, Swedish researchers report. Individuals with only one sibling with VTE are two times as likely to suffer the dangerous blood clots. This is the first study in a large population to show that the risk for VTE runs in families, the researchers say. VTE causes blood clots called deep vein thrombosis, which, if they break loose, can travel to the heart, lungs or brain and, if untreated, tend to be fatal. "We found genetic factors are important in the risk for VTE," said lead researcher Dr. Bengt Zoller, an associate professor, at the Center for Primary Health Care Research at Lund University in Malmo. "A sibling history of VTE is ... Read more
Related support groups: Venous Thromboembolism
Tall, Obese Men More Prone to Leg Clots: Study
Posted 1 May 2011 by Drugs.com
THURSDAY, April 28 – Men who are both obese and tall face a much higher risk for developing potentially fatal blood clots, though overall the risk remains quite small, according to a new study. The researchers report that extra weight and extra inches together seem to raise the risk more than either alone. "Tall and obese men had more than a fivefold higher risk, compared to short and lean men," said the study's co-author, Sigrid K. Braekkan, who warns the vertically and horizontally gifted to avoid sitting in one place for too long. Women also face a higher risk if they're both obese and tall, but just being tall alone doesn't seem to be a problem, the study found. The clots lead to a condition known as deep vein thrombosis, which may be best known as an affliction that strikes passengers on long plane flights who don't have much chance to move around. Immobilization of the legs can ... Read more
Related support groups: Venous Thromboembolism
Finding May Allow Some Women to Stop Blood Thinners
Posted 25 Aug 2008 by Drugs.com
MONDAY, Aug. 25 – A new study identifies some women – but not men – who might be able to stop taking blood-thinning medication for the clotting condition called venous thromboembolism. Current guidelines call for indefinite use of a clot-preventing drug, most often warfarin (Coumadin), for many people with the condition. But researchers report that they've identified a group of traits in women that indicate a very low risk of recurrent clots, so that medication might not be necessary after a few months. The study, published in the Aug. 26 issue of the Canadian Medical Association Journal, found no such indicators of low risk in men with the condition. The finding applies to what Dr. Marc A. Rodger, a senior scientist at the Ottawa Hearth Research Institute, who led the study, called "out-of-the-blue" venous thrombosis, with no obvious cause of clots in the legs, arms or lungs. In ... Read more
Related support groups: Coumadin, Venous Thromboembolism
Ask a Question
Further Information
Related Condition Support Groups
Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Thromboembolic Disorder